早期HPV相关舌根癌对侧颈隐匿转移风险研究
本研究回顾性分析106例接受经口机器人手术的早期HPV阳性舌根癌患者,评估对侧颈隐匿性淋巴结转移的发生率,并比较接受与未接受对侧颈治疗患者的生存和复发情况。结果显示对侧颈隐匿转移风险低,且对侧颈治疗与生存无显著差异,提示可考虑免除对侧颈治疗。
要点
- 早期HPV阳性舌根癌对侧颈隐匿转移风险低。
- 对侧颈治疗与否总生存和无病生存无显著差异。
- 可考虑免除早期HPV阳性舌根癌对侧颈治疗。
核心结论
- 早期HPV相关舌根癌手术后对侧颈隐匿性淋巴结转移风险低,可考虑免除对侧颈治疗。
研究设计与样本
- 回顾性队列研究,纳入106例AJCC第7版pT1-2、pN0-1 HPV阳性舌根癌患者,均接受经口机器人舌根切除、同侧颈清扫及辅助治疗。
主要发现
- 46例(43.3%)未接受对侧颈放疗或淋巴结清扫,29例(27.4%)仅接受对侧颈放疗,31例(29.2%)接受择区性对侧颈清扫但均未发现隐匿转移。
- 接受与未接受对侧颈治疗的患者总生存(HR:0.95,95%CI:0.23-4.00)和无病生存(HR:1.43,95%CI:0.55-3.71)无显著差异。
临床怎么用
- 对于早期HPV阳性舌根癌接受初次手术的患者,可考虑免除对侧颈治疗以避免相关并发症。
局限性
- 回顾性研究设计,样本来自单中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: (1) To determine the incidence of occult contralateral cervical lymph node metastasis in patients with early-stage HPV-associated base-of-tongue (BOT) oropharyngeal squamous cell carcinoma (OPSCC) treated with primary surgery; and (2) to compare survival and recurrence in patients who did and did not undergo contralateral neck treatment. BACKGROUND: Contralateral neck management in patients with early-stage HPV+ OPSCC of the BOT treated surgically remains controversial. Despite lacking data, most patients receive surgery and/or radiation to the contralateral neck based on historical incidence of occult lymph node metastasis in OPSCC. METHODS: A retrospective chart review of patients with AJCC 7th edition pT1-2, pN0-1 HPV+ BOT OPSCC undergoing transoral robotic BOT resection and ipsilateral neck dissection with adjuvant treatment was conducted. The incidence of occult contralateral nodal metastasis was assessed. Overall and disease-free survival were compared between patients who did and did not undergo contralateral neck treatment. RESULTS: Of 106 patients meeting inclusion criteria, 46 (43.3%) did not undergo treatment of the contralateral neck with radiation or lymphadenectomy, whereas 29 (27.4%) received radiation alone to the contralateral neck, and 31 (29.2%) underwent elective contralateral neck dissection without identification of occult metastasis in any case. Overall survival (HR: 0.95, 95% CI: 0.23-4.00) and disease-free survival (HR: 1.43, CI: 0.55-3.71) did not significantly differ between patients who did and did not receive treatment to the contralateral neck. CONCLUSION: Risk of occult contralateral cervical lymph node metastasis in patients with early-stage HPV-associated BOT OPSCC treated with primary surgery was low, prompting consideration of forgoing contralateral neck treatment in these patients.
引用
- Halle TR, Cao AC, Naik AG, et al. Risk of Occult Contralateral Neck Metastasis in Early-Stage HPV-Related Lateralized Cancer of the Base of the Tongue. Head Neck. 2025. PMID: 41367328. doi:10.1002/hed.70117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。